Pulmonx Corporation updated its revenue guidance for fiscal year 2023. For the period, the company is increasing its expectation to now range from $64 million to $66 million, which represents approximately 19% to 23% growth over the Company's fiscal year 2022 revenue. This updated guidance compares to prior 2023 revenue guidance of $63 million to $65 million.